Skip to main content
. 2021 Jan 12;21(3):202. doi: 10.3892/ol.2021.12463

Figure 5.

Figure 5.

Kaplan-Meier analysis of overall and disease-free survival in patients with lung adenocarcinoma according to MUC1-Tn expression. The 5-year overall survival rate was 87.9% for patients with MUC1-Tn-M or -L (n=131) and 69.3% for patients with MUC1-Tn-H (n=44; P=0.011). The 5-year disease-free survival rates were 79.6% for patients with MUC1-Tn-M or -L and 46.1% for patients with MUC1-Tn-H (P<0.001). MUC1-Tn, mucin 1 Tn-antigen; M, moderate; L, low; H, high.